Collectively, these and the foregoing results indicate that, unlike the case for all other members of the Mxd family and despite frequent and widespread LOH in a variety of cancers (Figure 2), there is currently little additional evidence to support a TS role for Mxd3 in human cancers. This evidence concerns the gene MXD3 and cancer.